<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00374101</url>
  </required_header>
  <id_info>
    <org_study_id>18/2004</org_study_id>
    <nct_id>NCT00374101</nct_id>
  </id_info>
  <brief_title>High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding</brief_title>
  <official_title>Proton Pump Inhibitors in Conjunction to Endoscopic Therapy for Bleeding Peptic Ulcers: a Randomized Clinical Trial of High vs Standard Doses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Casa Sollievo della Sofferenza IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Casa Sollievo della Sofferenza IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High intravenous dosage of Proton Pump Inhibitors is not better than standard dosage in
      bleeding peptic ulcers successfully treated by endoscopic therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The recent Canadian consensus conference on the management of patients with non-variceal
      upper gastrointestinal bleeding recommends a high regimen of PPIs, consisting in a dosage of
      80-mg bolus followed by the 8 mg/H infusion, as being superior to the standard dosage (40 mg
      twice daily by bolus injection) in conjunction with some type of endoscopic therapy. However,
      by pooling data fromm studies comparing high doses of PPIs as continuous infusion versus
      regular doses as intermittent bolus, rebleeding, surgery, and mortality were not
      significantly different. As the previous conclusion became apparent in a meta-analytical
      evaluation of only 2 randomized clinical trials, more studies are needed on this topic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rebleeding rates and surgical needs</measure>
  </primary_outcome>
  <enrollment>450</enrollment>
  <condition>Peptic Ulcers</condition>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>omeprazole</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pantoprazole</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients admitted for upper gastrointestinal bleeding secondary to peptic
             ulcers that have been successfully treated with endoscopic therapy

        Exclusion Criteria:

          -  Variceal esophageal bleeding

          -  Concurrent PPI use

          -  Moribund patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andriulli Angelo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Gastroenterology, &quot;Casa Sollievo della Sofferenza&quot;, San Giovanni Rotondo, ITALY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Internal Medicine</name>
      <address>
        <city>Polla</city>
        <state>Salerno</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Caserta</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIvision of Gastroenterology</name>
      <address>
        <city>Como</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Cosenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIvision of Internal Medicine</name>
      <address>
        <city>Ivrea</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Gastroenterology</name>
      <address>
        <city>Vasto</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Andriulli A, Annese V, Caruso N, Pilotto A, Accadia L, Niro AG, Quitadamo M, Merla A, Fiorella S, Leandro G. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol. 2005 Jan;100(1):207-19.</citation>
    <PMID>15654802</PMID>
  </reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2006</study_first_submitted>
  <study_first_submitted_qc>September 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2006</study_first_posted>
  <last_update_submitted>April 4, 2007</last_update_submitted>
  <last_update_submitted_qc>April 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2007</last_update_posted>
  <keyword>PPIs,</keyword>
  <keyword>endoscopic therapy,</keyword>
  <keyword>peptic ulcers,</keyword>
  <keyword>upper gastrointestinal bleeding,</keyword>
  <keyword>non-variceal upper gastrointestinal bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Omeprazole</mesh_term>
    <mesh_term>Pantoprazole</mesh_term>
    <mesh_term>Proton Pump Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

